Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCDHA5 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | ADD2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CRELD2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | MT-ND4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | MPHOSPH9 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | SLC25A43 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | UBE2W | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | RP11-831H9.11 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | UTP15 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | COL25A1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |